Nature Publishing Group
home
search




next week
7 August 2003
 nature view

Nature view

Research highlights from the NPG family of journals.


Animal memories: where did I put those nuts?

Animal memories: where did I put those nuts?Humans can mentally travel backwards in
time to recollect specific past events (episodic memory) and forwards to anticipate future needs (future planning). Until recently, there was little evidence that animals display either ability. But experiments on memory in food-storing birds question this assumption, showing that western scrub-jays form integrated and flexible memories of what they hid, where and when. Moreover, these birds can adjust their storing behaviour in anticipation of future needs. In an article in this month's Nature Reviews Neuroscience, Nicola Clayton et al. suggest that some animals have elements of both episodic-like memory and future planning.

opinion
Can animals recall the past and plan for the future?
N. S. CLAYTON, T. J. BUSSEY AND A. DICKINSON
Nature Reviews Neuroscience 4, 685; August 2003
| Summary | Full Text (HTML/PDF) |


Enter the matrix

Enter the matrixStudies of cell migration are moving into the next dimension — causing us to reassess the mechanisms that mediate cell motility. In the August issue of Nature Cell Biology, Eric Sahai and Christopher Marshall study the movement of tumour cells in three-dimensional matrices and note that there is remarkable plasticity in the mechanisms used to drive cell migration. Donna Webb and Alan Horwitz discuss in an accompanying News and Views article what we learn from this study about the requirements for different Rho-family GTPases in these migration patterns.

article
Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis
E. SAHAI AND C. J. MARSHALL
Nature Cell Biology 5, 711; August 2003
| Summary | Full Text (HTML/PDF) |

news and views
News dimensions in cell migration
D. J. WEBB AND A. F. HORWITZ.
Nature Cell Biology 5, 690; August 2003
| Summary | Full Text (HTML/PDF) |



Cancer vaccines: between the idea and the reality

Cancer vaccines: between the idea and the realityDeveloping cancer vaccines presents several unique hurdles. They must overcome any immune suppression exerted by the tumour, previous therapy or the effects of advanced age of the patient. If used for cancer prevention, vaccines must elicit effective long-term memory without the potential of causing autoimmunity. In a review in this month's Nature Reviews Immunology, Olivera Finn addresses the common and the unique challenges to cancer vaccines and the progress made in meeting them. As cancer has been resistant to standard therapy, efforts to achieve immune control of this disease are well justified. This article is available free online throughout August.

review
Cancer vaccines: between the idea and the reality
O. J. FINN
Nature Reviews Immunology 3, 630; August 2003
| Summary | Full Text (HTML/PDF) |


Decisions from opposing views

Decisions from opposing viewsImagine sitting next to a window in a restaurant atop a high building. You see people moving in the plaza below, and you instinctively direct your gaze in the direction that most people are moving. This effortless action — identifying the net direction of a more-or-less randomly moving group of objects — involves cortical neurons, which activate in response to visual objects moving in a particular direction, and inform the brain that an object is in motion. But how this neuronal representation is used to decide which direction a stimulus is moving has remained elusive. In the August issue of Nature Neuroscience, Jochen Ditterich et al. suggest that the brain combines sensory information from neurons tuned to opposite directions. Victor de Lafuente and Ranulfo Romo review in a News and Views article.

article
Microstimulation of visual cortex affects the speed of perceptual decisions
J. DITTERICH, M. E. MAZUREK AND M. N. SHADLEN
Nature Neuroscience 6, 891; August 2003
| Summary | Full Text (HTML/PDF) |

news and views
Decisions arising from opposing views
V. DE LAFUENTE AND R. ROMO
Nature Neuroscience 6, 787; August 2003
| Full Text (HTML/PDF) |


Gene polymorphisms and drug metabolism

Gene polymorphisms and drug metabolismAnalysis of the genes associated with drug modification and metabolism is a centerpiece of pharmacogenomic research. The UDP-glucuronosyltransferase (UGT) enzyme superfamily is a target of considerable interest in this regard - these proteins catalyze key metabolic reactions that protect the body against a variety of environmental and dietary toxins and carcinogens, and are also essential to the processing of a number of synthetic drugs and endogenous compounds. In the latest issue of The Pharmacogenomics Journal, Chantal Guillemette presents an extensive overview of the human UGTs, polymorphisms that have been identified in these genes, and the impact that these variations might have on cancer risk and responsiveness to various pharmacological treatments.

review
Pharmacogenomics of human UDP glucuronosyltransferase enzymes
C GUILLEMETTE
The Pharmacogenomics Journal 3, 136-158; (2003)
| Summary | Full Text (HTML/PDF) |

 


Mitochondrial DNA mutations in CLL cells

Mitochondrial DNA mutations in CLL cellsMutations in mitochondrial DNA (mtDNA) have long been observed in human cancer, however their significance in oncogenesis and chemosensitivity remains unclear. Huang et al’s study in the August issue of Leukemia examines the relationship between mtDNA mutations, reactive oxygen species (ROS) generation and clinical outcomes in chronic lymphocytic leukaemia (CLL). The mtDNA of 20 CLL patients was analysed, those with prior chemotherapy showed a higher frequency of mutations in primary CLL cells, which in turn appeared to be associated with increased ROS generation. Higher levels of ROS may contribute on the one hand to genetic instability and disease progression, but on the other, may also help to establish new therapeutics that will utilise enhanced levels of ROS to specifically target cancer cells.

article
Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications
J. S. CAREW, Y. ZHOU, M. ALBITAR, J. D. CAREW, M. J. KEATING & PENG HUANG
Leukemia 17, 1437; (2003)
| Summary | Full Text (HTML/PDF) |


  
  © 2003 Nature Publishing Group